Pendal Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Pendal Group's RGEN Position: Q4 2022 in Review
Pendal Group increased its Repligen (RGEN) stake by 4.1% in Q4 2022, buying an estimated $3.32M and bringing the position to 465,171 shares worth $78.8M. The position accounts for 0.68% of the portfolio, ranked #62.
Pendal Group first reported a position in RGEN in Q4 2020 and has held it in 4 quarters since. The position peaked at $83.6M in Q3 2022. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.
- Pendal Group held 465,171 shares of Repligen worth $78.8M as of Q4 2022.
- Pendal Group bought 18,308 Repligen shares in Q4 2022, an estimated $3.32M.
- Repligen made up 0.68% of Pendal Group's portfolio in Q4 2022, its #62 holding.
- Pendal Group first reported a position in Repligen in Q4 2020 and has held it in 4 quarters since.
- Pendal Group's Repligen position peaked at $83.6M in Q3 2022.
- 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.
Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.